ARCHIVES

FDA Approves Rituxan For CLL

This article is from The Cancer Letter archive.

Vol. 36 No. 06 | February 19, 2010

Download PDF Visit The Full Archive

Related Articles

Women’s Health Initiative Trial Produced $37.1 Billion in Returns

May 9, 2014

ASCO Study Predicts Shortage of Oncologists.

March 23, 2007

In Brief: FDA Approves G-CSF For Marketing; Walkmann Wins Belgian Health Prize; Green To Head NWTS

March 1, 1991

NCI To Offer Advice On Unconventional Therapy. Not Funds

December 14, 1990

Bypass Budget Going to White House Next Month Will Seek Optimal Funding for Cancer Program

August 22, 1980

NCI Intramural Programs: Clinical Trials Support System Need Attention, report Advises DCS

December 19, 1997